Tricida Inc
Change company Symbol lookup
Select an option...
TCDAQ Tricida Inc
HROWL HARROW HEALTH 8 625 SNR NTS
MLTX MoonLake Immunotherapeutics
TRTN Triton International Ltd
PAYA Paya Holdings Inc
MA Mastercard Inc
MWRK MetaWorks Platforms Inc
NSRGY Nestle SA
MIN MFS? Intermediate Income Fund
MCO Moody's Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Tricida, Inc. is a pharmaceutical company, which is focused on the development and commercialization of its investigational drug candidate, veverimer (TRC101). TRC101, is a non-absorbed, orally administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal (GI), tract. Its Veverimer, is a low-swelling, spherical polymer bead that is approximately 100 micrometers in diameter, which is a single, molecular weight, crosslinked polyamine molecule. It is conducting renal outcomes clinical trial, VALOR-CKD (TRCA-303), to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD. The Company's VALOR-CKD trial is a randomized, double-blind, placebo-controlled, time-to-event trial.

Closing Price
$0.0491
Day's Change
-0.0029 (-5.58%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0529
Day's Low
0.0427
Volume
(Light)
Volume:
5,327,152

10-day average volume:
23,112,362
5,327,152

Fox Corp. Cl A Stock Rises Tuesday, Still Underperforms Market

4:55 pm ET November 22, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Fox Corp. Cl A (FOXA) advanced 1.28% to $30.90 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 1.36% to 4,003.58 and the Dow Jones Industrial Average rising 1.18% to 34,098.10. Fox Corp. Cl A closed $14.05 below its 52-week high ($44.95), which the company reached on February 10th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Walt Disney Co. (DIS) fell 1.40% to $96.21, Netflix Inc. (NFLX) rose 0.58% to $286.69, and Comcast Corp. Cl A (CMCSA) rose 2.18% to $35.10. Trading volume (1.8 M) remained 1.4 million below its 50-day average volume of 3.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 22, 2022.

	

(END) Dow Jones Newswires

November 22, 2022 16:55 ET (21:55 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.